Foran, J. M., Zhang, Y., Heckman, M., Luger, S., Hulshizer, C., Vargas, E., … Cerhan, J. R. (2017). Prospective Study of Acute Myeloid Leukemia (AML) Clinical Epidemiology and Cytogenetic Risk Group in Older Adults in the ECOG-ACRIN E2906 Clinical Trial: The Acute Leukemia Epidemiology, Survival and Endpoints (ALESE) Study. In BLOOD (Vol. 130). Atlanta, GA: AMER SOC HEMATOLOGY.

Foran, James M., Yanming Zhang, Michael Heckman, Selina Luger, Cassondra Hulshizer, Emily Vargas, Mark R. Litzow, et al. “Prospective Study of Acute Myeloid Leukemia (AML) Clinical Epidemiology and Cytogenetic Risk Group in Older Adults in the ECOG-ACRIN E2906 Clinical Trial: The Acute Leukemia Epidemiology, Survival and Endpoints (ALESE) Study.” In BLOOD, Vol. 130. AMER SOC HEMATOLOGY, 2017.

Foran JM, Zhang Y, Heckman M, Luger S, Hulshizer C, Vargas E, et al. Prospective Study of Acute Myeloid Leukemia (AML) Clinical Epidemiology and Cytogenetic Risk Group in Older Adults in the ECOG-ACRIN E2906 Clinical Trial: The Acute Leukemia Epidemiology, Survival and Endpoints (ALESE) Study. In: BLOOD. AMER SOC HEMATOLOGY; 2017.

Foran, James M., et al. “Prospective Study of Acute Myeloid Leukemia (AML) Clinical Epidemiology and Cytogenetic Risk Group in Older Adults in the ECOG-ACRIN E2906 Clinical Trial: The Acute Leukemia Epidemiology, Survival and Endpoints (ALESE) Study.” BLOOD, vol. 130, AMER SOC HEMATOLOGY, 2017.

Foran JM, Zhang Y, Heckman M, Luger S, Hulshizer C, Vargas E, Litzow MR, Altman JK, Pratz K, Mattison R, Claxton DF, Uy GL, Erba HP, Cherry MA, Broun ER, Powell BL, Lazarus HM, Rowe JM, Paietta E, Little RF, Poynter J, Tallman MS, Cerhan JR. Prospective Study of Acute Myeloid Leukemia (AML) Clinical Epidemiology and Cytogenetic Risk Group in Older Adults in the ECOG-ACRIN E2906 Clinical Trial: The Acute Leukemia Epidemiology, Survival and Endpoints (ALESE) Study. BLOOD. AMER SOC HEMATOLOGY; 2017.